Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
A recent investigation by CNBC unveiled illegal sales and drug diversion, where medications produced for foreign markets are unlawfully shipped to the U.S.The shortage of drugs like Novo Nordisk A/S' (NYSE:NVO) Ozempic, Wegovy, and Eli Lilly And Co's (NYSE:LLY) Mounjaro and Zepbound have fueled an illicit market of counterfeit and diverted weight loss drugs, revealing an international issue that poses significant health risks.
藥品短缺，如諾和諾德公司（紐交所：NVO）的奧塞米，維格維和禮來公司（紐交所：LLY）的蒙茹哲別和澤邦德，已經推動了一場非法市場，湧現出假冒和轉移的減肥藥品，揭示了一個國際性問題，帶來了重大健康風險。
Last week, the FDA determined the shortage of Eli Lilly tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
上週，FDA確定了禮來替利塞肽注射劑的短缺問題已得到解決。替利塞肽是一種胰高血糖素樣肽-1（GLP-1）藥物。
Also Read: Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves.
此外閱讀：禮來向混合劑發出停止和中止信函，因減肥藥短缺問題得到解決。
A recent investigation by CNBC unveiled illegal sales and drug diversion, where medications produced for foreign markets are unlawfully shipped to the U.S.
CNBC最近的一項調查揭示了非法銷售和藥品轉移，製藥品專爲外國市場生產，非法運往美國。
Counterfeit drugs, disguised as popular weight loss medications, have emerged as a growing problem, targeting those seeking affordable alternatives.
僞造的藥品僞裝成流行的減肥藥物，已成爲一個日益嚴重的問題，針對那些尋求負擔得起的替代方案的人。
CNBC purchased what appeared to be Novo Nordisk's Ozempic from a company called Laver Beauty for a fraction of its U.S. list price.
CNBC購買了看似諾和諾德公司的奧塞米的產品，從一家名爲Laver Beauty的公司購買，價格僅爲其美國零售價的一小部分。
The drug, shipped from China, arrived without proper refrigeration, raising concerns about its safety. Novo Nordisk confirmed that the product was a "diverted legitimate product" intended for the Chinese market, making it unauthorized for use in the U.S.
這種藥品從中國運來，沒有得到適當的冷藏，引發了對其安全性的擔憂。諾和諾德確認該產品是面向中國市場的"轉移合法產品"，因此在美國使用是未經授權的。
The company emphasized that the product's sterility could not be verified, potentially increasing patients' risk of infection.
公司強調無法驗證該產品的無菌性，可能增加患者感染的風險。
Eli Lilly echoed similar concerns about counterfeit medications infiltrating the market.
禮來對於市場滲透的假藥問題表示擔憂。
Authorities in the U.K. have faced a surge in counterfeit weight loss drugs, with hundreds of Ozempic pens seized. Criminals exploit the high demand for these drugs by repurposing counterfeit insulin pens and labeling them as popular GLP-1 treatments.
英國當局面臨着假減肥藥激增的問題，數百支Ozempic針劑被扣押。犯罪分子利用這些藥物的高需求，重新包裝假的胰島素筆並將其標註爲熱門的GLP-1治療藥物。
Andy Morling, from the U.K.'s Medicines and Healthcare Products Regulatory Agency, noted that criminals often step in when supply and demand imbalances occur, making these drugs a prime target for counterfeiting.
英國藥品和保健產品監管局的Andy Morling指出，當供需失衡時，犯罪分子經常介入，使得這些藥物成爲假冒的主要目標。
U.S. Customs and Border Protection (CBP) has been actively intercepting counterfeit and diverted drugs at key entry points.
美國海關和邊境保護局（CBP）一直在關鍵入境點積極攔截假冒和轉移的藥物。
Sal Ingrassia, a CBP port director, stated that weight loss drugs such as Ozempic and Wegovy are frequently seized at ports of entry. Despite aggressive enforcement, many of these fake drugs make their way to U.S. customers, often ordered online or through social media platforms.
CBP港口董事Sal Ingrassia表示，諸如Ozempic和Wegovy之類的減肥藥物經常在口岸被扣押。儘管實施了積極執法，但許多這些假藥仍然流入美國消費者手中，經常是通過在線訂購或通過社交媒體平台購買。
CBP seizures of weight loss medications are expected to double this year, highlighting the escalating threat.
CBP對減肥藥物的扣押預計今年將翻倍，突顯出不斷增加的威脅。
In response, pharmaceutical companies are working closely with law enforcement and cybersecurity firms like BrandShield to shut down illegal websites and social media accounts selling counterfeit drugs.
爲應對此問題，藥企正與執法部門和像BrandShield這樣的網絡安全公司密切合作，關閉出售假藥的非法網站和社交媒體賬號。
While pharmaceutical companies like Novo Nordisk and Eli Lilly continue to innovate with treatments like retatrutide, criminals have already begun selling fake versions of the drug, which is still in clinical trials.
儘管藥企如諾和諾必達和禮來繼續創新試驗治療方法，犯罪分子卻已開始出售該藥物的假冒版本，該藥物仍處於臨床試驗階段。
Price Action: NVO stock is up 2.16% at $120.07, and LLY stock is up 1.53% at $924.65 at the last check Friday.
價格走勢： NVO股票上漲2.16%，報120.07美元，LLY股票上漲1.53%，報924.65美元，最後查看時間爲週五。
- JPMorgan Chase Q3 Earnings: Investment Banking Revenue Soars 29%, Largest Bank Raises Net Interest Income Outlook
- 摩根大通第三季度收益：投資銀行營收飆升29%，最大銀行上調淨利息收入展望
Image via Shutterstock
圖片來自shutterstock。
譯文內容由第三人軟體翻譯。
